Skip to content
★ Sign in to follow
TB

Timothy B. Lowinger

Directeur Scientifique et Technique
Mersana Therapeutics, Inc.
Total declarations
113
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (49 ops.)
€1.8M

Latest filing published 06 Jan 2026 for Mersana Therapeutics, Inc..

Insider track record

Disclosed buys
0
Disclosed sells
49

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Timothy B. Lowinger: trading record in brief

Timothy B. Lowinger (senior executive) discloses dealings in Mersana Therapeutics, Inc. to SEC (Form 4). We count 113 filings; the first trade dates from 21 February 2018 and the latest from 6 January 2026.

No open-market purchase appears, only 49 sales worth €1.8M. Other entries cover 1 share grant and 62 option exercises.

The newest entry dates from 6 January 2026: a transaction, in Mersana Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Timothy B. Lowinger

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations17 total

17 of 17 declarations